Scientists revealed that Janus kinase (JAK)–signal transducer and activator of transcription (STAT) signaling was a crucial executor in promoting lineage plasticity-driven androgen receptor (AR)-targeted therapy resistance in prostate cancer.
[Nature Cancer]